Key result
Higher peri-atrial adipose tissue density is linked to ~9% greater AF odds per HU increase.
Why the study?
Inflammation plays a key role in AF, and epicardial adipose tissue around the atrial wall influences atrial morpho-functional properties, prompting evaluation of whether increased quantity or density of peri-left atrial fat relates to AF independently of atrial size.
Is increased quantity or density of left atrial epicardial adipose tissue associated with atrial fibrillation independently of atrial size?
Case-Control (n=160)
No
Is increased quantity or density of left atrial epicardial adipose tissue associated with atrial fibrillation independently of atrial size?
Odds Ratio: 1.09 (95% CI 1.03–1.11)
Absolute Event Rate: -69.15% vs -76.82%
p-value: p=0.006
Higher left atrial epicardial adipose tissue density on CCTA is associated with atrial fibrillation independently of left atrial size, suggesting a role for peri-atrial inflammation.
Should not change practice; hypothesis-generating for peri-atrial inflammation beyond atrial size in AF.
Background: Inflammation plays a key role in atrial fibrillation (AF). Epicardial adipose tissue around the atrial wall can influence atrial morpho-functional properties. The aim of this study was to assess whether an increased quantity and/or density of adipose tissue located around the left atrium (Fat-LA) are related to AF, independently from atrial size. Methods: eighty patients who underwent AF ablation and 80 patients without history of AF were selected. The Fat-LA mass was quantified as tissue within −190 to −30 Hounsfield Units (HU) on cardiac computed tomography angiograms (CCTA), and the mean adipose tissue attenuation was assessed. Results: Adipose tissue mass was higher in patients with AF (5.42 ± 2.94 mL) versus non-AF (4.16 ± 2.55 mL, p = 0.007), but relative fat quantity did not differ after adjusting for atrial size. Mean fat density was significantly higher in AF (−69.15 HU) versus non-AF (−76.82 HU, p < 0.0001) participants. In the logistic regression models, only the addition of mean Fat-LA attenuation led to a significant improvement of the model’s chi-square (from 22.89 of the clinical model to 31.69 of the clinical and adipose tissue attenuation model, p < 0.01) and discrimination (AUC from 0.775 to 0.829). Conclusions: Fat-LA volume is significantly greater only in absolute terms in patients with AF, but this difference does not hold after adjusting for the larger LA of AF subjects. On the contrary, a higher Fat-LA density was associated with AF, independently from LA size, providing incremental value over other variables that are associated with AF.
No takes yet. Share an insight, caveat, or question.
Gaibazzi et al. (2021) conducted a case-control in Atrial Fibrillation (n=160). Peri-atrial adipose tissue (Fat-LA) attenuation vs. Patients without atrial fibrillation was evaluated on Association of Fat-LA mean attenuation with atrial fibrillation (OR 1.09, 95% CI 1.03-1.11, p=0.006). Higher peri-atrial adipose tissue density was independently associated with atrial fibrillation (OR 1.09 per HU increase), providing incremental predictive value over clinical variables and left atrial size.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: